Watch Presentation:
From State Spending to the Medicine Cabinet: Unlocking 340B Insights That Shape Patient Costs and Care

From State Spending to the Medicine Cabinet: Unlocking 340B Insights That Shape Patient Costs and Care

Wednesday, June 3, 2026

The 340B Drug Pricing Program continues to be an important area of focus for policymakers, healthcare stakeholders, and patient advocates as questions around transparency, accountability, and patient benefit remain central to the policy conversation.

In this webinar, HEAL Collaborative and Magnolia Market Access discuss findings from a new state-by-state analysis examining how hospitals participating in the 340B program allocate program revenues. The research provides a closer look at whether and how 340B resources are being directed toward patient care, uncompensated care, and support for vulnerable and underserved communities.

The discussion connects the analysis to broader healthcare access considerations, including what the findings may mean for policy, program oversight, and efforts to ensure that 340B resources are aligned with the needs of the patients and communities the program was intended to support.

Why Watch:
In this session, you will gain perspective on:

  • Findings from a first state-by-state analysis of 340B revenue allocation practices
  • How hospitals participating in the 340B program are using revenues across states
  • What the analysis suggests about whether 340B revenues are translating into meaningful investments in patient care
  • Key questions related to transparency, accountability, patient benefit, and healthcare access

Panelists include: